Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
REPRO-MED Systems (KRMD) Stock Price & Analysis
270 Followers
KRMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.98 - $3.12
Previous Close$2.47
Volume38.65K
Average Volume (3M)205.01K
Market Cap
$113.04M
Enterprise Value$106.39M
Total Cash (Recent Filing)$10.82M
Total Debt (Recent Filing)$4.17M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Aug 07, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding45,764,225
10 Day Avg. Volume119,319
30 Day Avg. Volume205,007
Standard Deviation0.19
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)6.19
Price to Sales (P/S)4.25
Price to Cash Flow (P/CF)27.60
P/FCF Ratio33.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.63
Enterprise Value/Gross Profit6.37
Enterprise Value/Ebitda-13.26
Forecast
1Y Price Target
$3.67Price Target Upside48.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
REPRO-MED Systems News
PremiumCompany Announcements
REPRO-MED Systems Announces Executive Leadership Changes
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ1 revenue of $8.2M was above expectations, showcasing a strong start to the year.
Market ExpansionThe signing of a third partner in the Novel Therapies business indicates progress in diversifying partnerships.
Product InnovationThe company's proprietary Freedom System is the only FDA-approved pump for large volume prefilled syringes in the U.S., positioning it well to capitalize on this growing market segment.
Bears Say
Competitive PressuresPotential for competitive pressures to expand, posing a risk to market share and profitability.
Margin PressureKORU Medical Systems may experience margin pressure from increasing inflationary, material, and labor costs despite global expansion efforts.
Revenue DeclineNovel Therapies revenue was down, suggesting challenges in that business segment.
---
Ownership Overview
27.04% Insiders
6.43% Mutual Funds
5.93% Other Institutional Investors
60.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $1.98 and its highest was $3.12 in the past 12 months.
What is REPRO-MED Systems’s market cap?
Currently, no data Available
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is Aug 07, 2024 which is in 11 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on May 01, 2024. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.038 by -$0.002.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -$0.04.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 45,764,225 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.038. Following the earnings report the stock price went up 5.778%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Among the largest hedge funds holding REPRO-MED Systems’s share is Horton Capital Management, LLC. It holds REPRO-MED Systems’s shares valued at 25M.
---
REPRO-MED Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.67 (48.58% Upside)
$3.67 (48.58% Upside)
Blogger Sentiment
Neutral
KRMD Sentiment 50%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.18%
12-Months-Change
Fundamentals
Return on Equity
-54.24%
Trailing 12-Months
Asset Growth
-28.11%
Trailing 12-Months
Company Description
REPRO-MED Systems
Repro-Med Systems, Inc.engages in the design, manufacture, and market of proprietary medical devices. It products include FREEDOM60, a syringe infusion pump, which is designed for ambulatory medication infusions; HIgH-Flo, is designed for self-administration of medicine under the skin; and RES-Q-VAC, is a portable and hand-operated suction device that removes fluids from a patients airway. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.
---
KRMD Company Deck
---
KRMD Earnings Call
Q1 2024
0:00 / 0:00
---
KRMD Stock 12 Month Forecast
Average Price Target
$3.67
▲(48.58% Upside)
Technical Analysis
Best Analysts Covering KRMD
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+9.33%
reiterated a buy rating 3 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +9.33% per trade.
---